NCT02360800View on ClinicalTrials.gov

Trial Comparing Tisseel as an Adjunct to Traditional Hemostasis After Redo Cardiac Surgery

NACompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

February 2, 2017

Primary Completion Date

June 3, 2018

Study Completion Date

September 16, 2018

Conditions
Hemorrhage
Interventions
PROCEDURE

Spray Fibrin Sealant

Baxter Tisseel (Fibrin Sealant) is sprayed in the mediastinum at the end of the operation afetr routine chest hemostasis protocol has been completed, right before closing the chest.

PROCEDURE

Traditional Hemostasis and chest Closure Routine

Routine chest hemostasis and closure protocol (gauzes and inspection till satisfactory according to the surgeon)

Trial Locations (1)

00149

European Hospital, Rome

All Listed Sponsors
lead

Cardiochirurgia E.H.

OTHER

NCT02360800 - Trial Comparing Tisseel as an Adjunct to Traditional Hemostasis After Redo Cardiac Surgery | Biotech Hunter | Biotech Hunter